The global HIV diagnostics market size was evaluated at USD 3,498 million in 2024 and is expected to grow around USD 7,277 million by 2034, registering a CAGR of 7.6% from 2025 to 2034.
The HIV diagnostics market focuses on developing, producing and distribution of diagnostics tools for monitoring HIV viruses. The market for HIV diagnostics is expected to propel due to the growing rates of infected patients and the high percentage of untreated infections. Awareness and testing are important in combating the epidemic as well as in the healthcare of individuals. The growing need for HIV diagnostics has been related to the need to recognize certain types of viruses that cause acquired immune deficiency syndrome (AIDS). HIV testing is performed using either serum, saliva, or urine samples to check if the virus is present.
Nevertheless, there are challenges associated with market penetration, such as the high price of nucleic acid testing (NAT) and the fact that there are no NAT prerequisites in developing economies. The desire and the ability of healthcare facilities to acquire and use NAT technologies diminishes when there is no pressure or financial assistance, from either the state or global health agencies, which unfortunately hampers the response towards the control and reduction of the virus transmission.
Advanced technology is further propelling the growth of the market. The growth of the market can be attributed to the rising awareness levels on HIV, the increasing measures aimed at enhancing confidentiality of testing, improved availability of the tests, and counseling services.
| Industry Worth | Details |
| Market Size in 2025 | USD 3,765 Million |
| Market Size by 2034 | USD 7,277 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 7.6% |
Published by Rohan Patil
